Live Chat

Illegal Kickbacks for Prescribing Risperdal Leads to a $2.2 Billion Settlement

A Johnson & Johnson (J&J) employee, Judy Doetterl, was awarded almost $30 million in whistleblower compensation because she was able to obtain proof that the company J&J had been marketing illegal through kickback schemes in association with the drug Risperdal. Doetterl wore a recording device to one of the company’s marketing presentations. Doetterl and other employees encouraged the government to investigate further into the company because of the certain occurrences they experienced at work. As a result of this investigation, the US Department of Justice pursued charges against J&J for their illegal marketing. The company would allegedly offered kickbacks to doctors if they would push their powerful antipsychotic on patients. This ultimately led to a $2.2 billion settlement agreement to settle the Risperdal claims.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at or by calling 1.866.705.7584.

Drug Litigation